Lista de obras - Agnes I. Vitry - Dominio Público Uruguay

Access to Controlled Medicines in Low-Income Countries: Listening to Stakeholders in the Field

artículo científico publicado en 2020

Access to new cancer medicines in Australia: dispelling the myths and informing a public debate

artículo científico publicado en 2016

Advertising of antihypertensive medicines and prescription sales in Australia

article

Ageing well: improving the management of patients with multiple chronic health problems

artículo científico publicado en 2011

Analgesic Use and Daytime Sleepiness in Residents With and Without Dementia in Residential Aged Care Facilities.

artículo científico publicado en 2015

Analgesic use and pain in residents with and without dementia in aged care facilities: A cross-sectional study

artículo científico publicado en 2016

Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.

artículo científico publicado en 2014

Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing

artículo científico publicado en 2010

Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease

artículo científico publicado en 2010

Assessment of the therapeutic value of new medicines marketed in Australia

artículo científico publicado en 2013

Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis.

artículo científico publicado en 2017

Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

artículo científico publicado en 2015

Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014.

artículo científico publicado en 2018

Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide

article

Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting

artículo científico publicado en 2010

Chronic disease management: does the disease affect likelihood of care planning?

artículo científico publicado en 2012

Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data

artículo científico publicado en 2011

Co-morbidity and the utilization of health care for Australian veterans with diabetes

artículo científico publicado en 2010

Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study.

artículo científico publicado en 2009

Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications

artículo científico publicado en 2013

Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis

artículo científico publicado en 2018

Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts

artículo científico publicado en 2009

Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants

artículo científico publicado en 2010

Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study

artículo científico publicado en 2017

Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme

artículo científico publicado en 2015

Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study

scientific article published on 02 May 2018

Direct-to-consumer advertising policy in Australia: realism in whose interests?

article

Discounting of medicines in Australian community pharmacies

article

Disease burden, comorbidity and geriatric syndromes in the Australian aged care population.

artículo científico publicado en 2017

Disease mongering and low testosterone in men: the tale of two regulatory failures ⬇️

artículo científico publicado el 4 de junio de 2012

Does antidepressant medication use affect persistence with diabetes medicines?

artículo científico

Drug advertisements in medical journals

artículo científico publicado en 1997

Drug advertising in medical journals

Drug marketing in French-speaking African countries.

artículo científico publicado en 1993

Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes.

artículo científico publicado en 2016

Evaluating medication-related quality of care in Australian aged care: a role for collaborative health services

article

Evaluating medication-related quality of care in residential aged care: a systematic review

artículo científico publicado en 2015

General practitioner management plans delaying time to next potentially preventable hospitalisation for patients with heart failure

artículo científico publicado en 2014

Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study

artículo científico publicado en 2018

Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?

artículo científico publicado en 2010

Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study

artículo científico publicado en 2010

Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity

artículo científico publicado en 2017

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review

artículo científico publicado en 2010

Is Australia's national medicines policy failing? The case of COX-2 inhibitors.

artículo científico publicado en 2007

Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison.

artículo científico publicado en 2014

Major bleeding risk associated with warfarin and co-medications in the elderly population

scientific article published on 01 October 2011

Managed entry agreements for pharmaceuticals in Australia

article

Medication-related quality of care in residential aged care: an Australian experience

scientific article published on 01 May 2019

Medicines access programs to cancer medicines in Australia and New Zealand: An exploratory study

artículo científico publicado en 2017

Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia

artículo científico publicado en 2010

Multimorbidity, care complexity and prescribing for the elderly

article

Patterns of comorbidities in women with breast cancer: a Canadian population-based study

scientific article published on 06 July 2019

Patterns of health service utilisation among the Australian population with cancer compared with the general population

scientific article published on 07 November 2019

Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis.

artículo científico publicado en 2019

Pharmaceutical Pricing Policies in Australia

article

Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data

artículo científico publicado en 2010

Prevalence of comorbidity of chronic diseases in Australia

artículo científico publicado en 2008

Price and utilisation differences for statins between four countries

artículo científico publicado en 2017

Provision of information on regulatory authorities' websites

artículo científico publicado en 2008

Provision of medicines information in Australian community pharmacies.

artículo científico publicado en 2009

Quality and availability of consumer information on heart failure in Australia

artículo científico publicado en 2008

Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States

artículo científico publicado en 2010

Quality of pharmaceutical advertisements in medical journals: a systematic review

artículo científico publicado en 2009

Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study

artículo científico publicado en 2015

Reporting of studies on new medicines in major medical journals: a case study in breast cancer

artículo científico publicado en 2010

Response to Michael Wonder's comments on the article 'Assessment of the therapeutic value of new medicines marketed in Australia'

artículo científico publicado en 2013

Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population

artículo científico publicado en 2009

Serious statin-associated myotoxicity and rhabdomyolysis in Aboriginal and Torres Strait Islanders: a case series

scientific article published on 01 September 2013

Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia.

artículo científico publicado en 2016

The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy

article

The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes

artículo científico publicado en 2010

The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people

artículo científico publicado en 2009

Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia

artículo científico publicado en 2011

Transparency is good, independence from pharmaceutical industry is better!

artículo científico publicado en 2016

Trends in general practitioner services to residents in aged care

artículo científico publicado en 2016

Validity of medication-based co-morbidity indices in the Australian elderly population

artículo científico publicado en 2009

Lista de obras de Agnes I. Vitry

Access to Controlled Medicines in Low-Income Countries: Listening to Stakeholders in the Field

Access to new cancer medicines in Australia: dispelling the myths and informing a public debate

Advertising of antihypertensive medicines and prescription sales in Australia

Ageing well: improving the management of patients with multiple chronic health problems

Analgesic Use and Daytime Sleepiness in Residents With and Without Dementia in Residential Aged Care Facilities.

Analgesic use and pain in residents with and without dementia in aged care facilities: A cross-sectional study

Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.

Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing

Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease

Assessment of the therapeutic value of new medicines marketed in Australia

Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis.

Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014.

Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide

Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting

Chronic disease management: does the disease affect likelihood of care planning?

Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data

Co-morbidity and the utilization of health care for Australian veterans with diabetes

Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study.

Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications

Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis

Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts

Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants

Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study

Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme

Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study

Direct-to-consumer advertising policy in Australia: realism in whose interests?

Discounting of medicines in Australian community pharmacies

Disease burden, comorbidity and geriatric syndromes in the Australian aged care population.

Disease mongering and low testosterone in men: the tale of two regulatory failures ⬇️

Does antidepressant medication use affect persistence with diabetes medicines?

Drug advertisements in medical journals

Drug advertising in medical journals

Drug marketing in French-speaking African countries.

Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes.

Evaluating medication-related quality of care in Australian aged care: a role for collaborative health services

Evaluating medication-related quality of care in residential aged care: a systematic review

General practitioner management plans delaying time to next potentially preventable hospitalisation for patients with heart failure

Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study

Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?

Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study

Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review

Is Australia's national medicines policy failing? The case of COX-2 inhibitors.

Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison.

Major bleeding risk associated with warfarin and co-medications in the elderly population

Managed entry agreements for pharmaceuticals in Australia

Medication-related quality of care in residential aged care: an Australian experience

Medicines access programs to cancer medicines in Australia and New Zealand: An exploratory study

Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia

Multimorbidity, care complexity and prescribing for the elderly

Patterns of comorbidities in women with breast cancer: a Canadian population-based study

Patterns of health service utilisation among the Australian population with cancer compared with the general population

Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis.

Pharmaceutical Pricing Policies in Australia

Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data

Prevalence of comorbidity of chronic diseases in Australia

Price and utilisation differences for statins between four countries

Provision of information on regulatory authorities' websites

Provision of medicines information in Australian community pharmacies.

Quality and availability of consumer information on heart failure in Australia

Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States

Quality of pharmaceutical advertisements in medical journals: a systematic review

Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study

Reporting of studies on new medicines in major medical journals: a case study in breast cancer

Response to Michael Wonder's comments on the article 'Assessment of the therapeutic value of new medicines marketed in Australia'

Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population

Serious statin-associated myotoxicity and rhabdomyolysis in Aboriginal and Torres Strait Islanders: a case series

Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia.

The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy

The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes

The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people

Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia

Transparency is good, independence from pharmaceutical industry is better!

Trends in general practitioner services to residents in aged care

Validity of medication-based co-morbidity indices in the Australian elderly population